8-K: IMAC Holdings Appoints Jeffrey Busch to Board of Directors

IMAC Holdings, Inc. has appointed Jeffrey Busch, a seasoned executive with extensive experience in healthcare and public service, to its Board of Directors effective September 19, 2024.

Summary

• IMAC Holdings, Inc. announced the appointment of Jeffrey Busch to its Board of Directors on September 19, 2024.
• Mr. Busch has a strong background in healthcare, having served as Chairman of the Board of Theralink Technologies, Inc., from which IMAC acquired assets in May 2024.
• He is also the current Chairman and CEO of Global Medical REIT, a NYSE-listed company.
• Mr. Busch's career includes roles as a Presidential Appointee, entrepreneur, and investor in various asset classes, including medical and pharmaceutical.
• He has held senior positions in two U.S. presidential administrations and represented the United States before the United Nations in Geneva, Switzerland.
• Mr. Busch has also served as a top advisor to several publicly traded medical companies and worked in the medical, blood supply, and management fields.
• He holds degrees from New York University Stern School of Business, New York University, and Emory University.

Sentiment

Score: 7

Explanation: The appointment of an experienced and well-connected individual to the board is generally viewed positively by investors, suggesting a moderate positive sentiment.

Positives

• The appointment of Jeffrey Busch brings significant experience in healthcare, public service, and investment to the IMAC Holdings Board.
• Mr. Busch's leadership at Global Medical REIT and Theralink Technologies suggests a strong understanding of the medical industry.
• His background as a Presidential Appointee and advisor to publicly traded medical companies indicates a high level of expertise and connections.
• Mr. Busch's experience in establishing medical facilities in developing nations could be valuable for IMAC's growth strategy.

Management Comments

• Faith Zaslavsky, Chief Executive Officer of IMAC Holdings, signed the report on behalf of the company.

Industry Context

The appointment of a seasoned healthcare executive like Jeffrey Busch to the board is a positive move for IMAC Holdings, aligning with the trend of companies seeking experienced leadership to navigate the complex healthcare landscape.

Comparison to Industry Standards

• The appointment of a board member with experience as a CEO of a NYSE listed company is a common practice for companies seeking to enhance their corporate governance and strategic direction.
• Many companies in the healthcare sector seek board members with a mix of operational, financial, and regulatory expertise, which Mr. Busch appears to possess.
• The appointment of a board member with experience in both public and private sectors is also a common practice to bring diverse perspectives to the board.

Management Changes

Stakeholder Impact

• The appointment of Jeffrey Busch could positively impact shareholders by bringing additional expertise and potentially enhancing the company's strategic direction.
• The appointment is unlikely to have a direct impact on employees, customers, suppliers, or creditors in the short term.

Key Dates

Keywords

Board of Directors, Healthcare, Medical, Appointment, Jeffrey Busch, IMAC Holdings, Global Medical REIT, Theralink Technologies, Public Service, Corporate Governance